ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Piramal Pharma Solutions plans to invest $32 million at its active pharmaceutical ingredient facility in Riverside, Michigan. The project will add 2,300 m2 of space, including 790 m2 of production space, at the former Ash Stevens plant, which the Indian contract manufacturer purchased in 2016. Plans include a 4,000 L reactor for large-scale production, two kilo labs for process development and clinical-scale production, and a 3,000 L Hastelloy reactor to handle potent compounds. The expansion is expected to add 20 jobs when completed in 2022.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X